Korean J Urol.
2001 Jun;42(6):657-662.
The Effects of Selective Norepinephrine Reuptake Inhibitors (SNRIs) on the Urethral Pressure
- Affiliations
-
- 1Department of Urology, Korea University College of Medicine, Seoul, Korea.
Abstract
-
PURPOSE: This study was performed to identify the effects of selective norepinephrine
reuptake inhibitor (SNRI, venlafaxine) on the urethral perfusion pressure (UPP) and also
to assess its therapeutic potentials for stress urinary incontinence.
MATERIALS AND METHODS
Smooth muscle strips of bladder and proximal urethra were
prepared using female New Zealand white rabbits. Each strip was electrically stimulated
and the degree of strip contraction was recorded by polygraph. After administration
of venlafaxine (10(-6)M), responses of strips to electrical stimulation were measured.
In separate experiments of eighty adult female Sprague Dawley rats, intravesical
pressure and UPP was measured separately via double lumen catheter. Changes of
intravesical pressure and UPP to intra-arterial (i.a.) and intra-urethral (i.u.) administra
tion of phenylephrine, phentolamine, nitroprusside, fluoxetine (SSRIs), and venlafaxine
were monitored, respectively.
RESULTS
In strip study, pretreatment of venlafaxine significantly decreased the contrac
tion of bladder strips (p=0.01) and significantly increased the contraction of urethral
strips (p=0.008). In separate experiment of in vivo animal study, phenylephrine signifi
cantly increased the UPP. Phentolamine (i.a.) significantly decreased the UPP (p=
0.001). UPP was also significantly decreased by intra urethral infusion of nitroprusside
(p=0.003), but not significantly decreased by intra-arterial nitroprusside (p=0.23).
Fluoxetine (i.a.) did not increase UPP significantly (p=0.15). Venlafaxine (i.a. and i.u.)
significantly increased UPP (p=0.0002, 0.0001), respectively. In each case, intravesical
pressure was not changed significantly.
CONCLUSIONS
These results demonstrate that SNRI increases UPP in vitro and in vivo
animal study. These results imply that venlafaxine may be useful for treatment of stress
urinary incontinence by increasing UPP.